MannKind Corp (MNKD)
7.02
+0.06
(+0.86%)
USD |
NASDAQ |
Nov 14, 16:00
7.26
+0.24
(+3.42%)
After-Hours: 07:50
MannKind Cash from Investing (Quarterly): -41.26M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -41.26M |
| June 30, 2024 | -55.18M |
| March 31, 2024 | -48.44M |
| December 31, 2023 | -7.895M |
| September 30, 2023 | -11.55M |
| June 30, 2023 | 3.664M |
| March 31, 2023 | 13.79M |
| December 31, 2022 | 15.01M |
| September 30, 2022 | 27.35M |
| June 30, 2022 | 2.022M |
| March 31, 2022 | -39.51M |
| December 31, 2021 | -12.58M |
| September 30, 2021 | 4.992M |
| June 30, 2021 | -112.53M |
| March 31, 2021 | -31.42M |
| December 31, 2020 | -4.48M |
| September 30, 2020 | -0.004M |
| June 30, 2020 | -0.15M |
| March 31, 2020 | 19.85M |
| December 31, 2019 | -0.202M |
| September 30, 2019 | 3.761M |
| June 30, 2019 | -1.369M |
| March 31, 2019 | -25.03M |
| December 31, 2018 | -0.244M |
| September 30, 2018 | 0.01M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.024M |
| March 31, 2017 | 16.65M |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | -1.127M |
| December 31, 2015 | -0.312M |
| September 30, 2015 | -1.154M |
| June 30, 2015 | -4.534M |
| March 31, 2015 | -4.203M |
| December 31, 2014 | -14.21M |
| September 30, 2014 | -0.217M |
| June 30, 2014 | -8.258M |
| March 31, 2014 | -1.409M |
| December 31, 2013 | -6.166M |
| September 30, 2013 | -0.23M |
| June 30, 2013 | -0.132M |
| March 31, 2013 | -1.459M |
| December 31, 2012 | -0.061M |
| September 30, 2012 | -0.124M |
| June 30, 2012 | -0.084M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-112.53M
Minimum
Jun 2021
27.35M
Maximum
Sep 2022
-13.93M
Average
-2.341M
Median
Cash from Investing (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | -72.72M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | -0.0049M |
| iBio Inc | -0.144M |
| Theriva Biologics Inc | -0.001M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.331M |
| Cash from Financing (Quarterly) | -2.342M |
| Free Cash Flow | 28.87M |
| Free Cash Flow Per Share (Quarterly) | 0.0278 |
| Free Cash Flow to Equity (Quarterly) | 7.55M |
| Free Cash Flow to Firm (Quarterly) | 12.56M |
| Free Cash Flow Yield | 1.43% |